Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Cardinal Health

- PMLiVE

US Supreme Court halts Purdue Pharma $6bn bankruptcy settlement

The company has been blamed for fuelling the opioid crisis by promoting its drug OxyContin

- PMLiVE

FDA external report recommends actions to address US opioid crisis

Over 100,000 Americans died from a drug overdose in 2021, with 70,000 of those due to opioids

- PMLiVE

Teva reaches proposed $4.25bn agreement to settle US opioid lawsuits

The figure includes the supply of up to $1.2bn of Teva’s Narcan, a life-saving medication which can reverse an overdose from opioids

- PMLiVE

J&J, distributors reach $26bn settlement to address the opioid crisis in the US

The proposed agreement would resolve claims of both states and local governments in the US

- PMLiVE

US states claim Purdue Pharma owes $2.2 trillion over opioid crisis

Company faces new accusations of dishonest marketing tactics

- PMLiVE

US states reject drug distributors’ opioid settlement

The Wall Street Journal reports at least 21 states want a larger settlement

- PMLiVE

Johnson & Johnson agrees $20.4m settlement in Ohio over opioid crisis

Will avoid upcoming federal trial as a result

- PMLiVE

J&J found liable in first opioid mis-marketing verdict

Oklahoma challenge a milestone, but company will appeal

- PMLiVE

J&J sells Cordis unit to Cardinal Health for $1.94bn

Marks J&J’s exit from the cardiovascular stent market

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links